{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:21:21Z","timestamp":1791328881728,"version":"4.3.1"},"reference-count":48,"publisher":"Georg Thieme Verlag KG","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Horm Metab Res"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There have been 2, and possibly 3, major questions for primary aldosteronism (PA)\n                    answered at least in principle over the past 5 years. The first is that of\n                    somatic mutations underlying the majority of aldosterone producing adenomas. The\n                    second is the extension of our knowledge of the genetics of familial\n                    hypertension, and the third the role of renal intercalated cells in sodium\n                    homeostasis. New questions for the next 5 years include a single accepted\n                    confirmatory\/exclusion test; standardisation of assays and cut-offs;\n                    alternatives to universal adrenal venous sampling; reclassification of \u2018low\n                    renin hypertension\u2019; recognition of the extent of \u2018occult\u2019 PA; inclusion of\n                    low-dose mineralocorticoid receptor antagonist in first-line therapy for\n                    hypertension; and finally, possible resolution of the aldosterone\/inappropriate\n                    sodium status enigma at the heart of the cardiovascular damage in PA.<\/jats:p>","DOI":"10.1055\/s-0035-1565182","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T23:41:22Z","timestamp":1448062882000},"page":"935-940","source":"Crossref","is-referenced-by-count":4,"title":["Primary Aldosteronism: New Answers, New Questions"],"prefix":"10.1055","volume":"47","author":[{"given":"J. W.","family":"Funder","sequence":"additional","affiliation":[{"name":"Hudson Institute of Medical Research and Monash University, Clayton,\n                    Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2015,11,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Endocrine Society. Case detection, diagnosis and treatment of patients with\n                    primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"J W Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society.\n                    Guidelines for the diagnosis and treatment of primary aldosteronism \u2013 the Japan\n                    Endocrine Society 2009","volume":"58","author":"T Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and\n                    hereditary hypertension","volume":"331","author":"M Choi","year":"2011","journal-title":"Science"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary\n                    aldosteronism","volume":"59","author":"S Boulkroun","year":"2012","journal-title":"Hypertension"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas\n                    and secondary hypertension","volume":"45","author":"F Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal\n                    hypertension","volume":"45","author":"E A Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone producing\n                    adenomas and primary aldosteronism","volume":"45","author":"U I Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and\n                    early-onset autosomal dominant hypertension","volume":"97","author":"E Charmandari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial\n                    hyperaldosteronism","volume":"59","author":"P Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal\n                    three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"T Akerstrom","year":"2012","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/HJH.0b013e328356139f","article-title":"Characterization of a novel somatic KCNJ5 mutation dell157 in an\n                    aldosterone-producing adenoma","volume":"30","author":"M Murthy","year":"2012","journal-title":"J Hypertens"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"E1861","DOI":"10.1210\/jc.2013-2428","article-title":"A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type\n                    III","volume":"98","author":"S Monticone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"E1765","DOI":"10.1210\/jc.2014-1927","article-title":"A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity\n                    filter causes resistant hypertension by loss of selectivity for potassium","volume":"99","author":"M Kuppusamy","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1210\/jc.2014-3009","article-title":"Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4\n                    membrane abundance","volume":"100","author":"C J Cheng","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hypersecretion in a substantial subset of patients\n                    with essential hypertension","volume":"100","author":"A Markou","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636\n                    patients with an aldosterone-producing adenoma","volume":"100","author":"L Lenzini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2\n                    large unselected collections of adrenal aldosteronomas","volume":"59","author":"E A Azizan","year":"2012","journal-title":"Hypertension"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nrendo.2012.230","article-title":"Role of KCNJ5 in familial and sporadic primary aldosteronism","volume":"9","author":"P Mulatero","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with\n                    aldosterone-producing adenomas","volume":"97","author":"R Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.24455","article-title":"Comparison of cardiovascular complications in patients with and without KCNJ5\n                    gene mutations harboring aldosterone-producing adenomas","volume":"22","author":"T Kitamoto","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with\n                    aldosterone-producing adenoma","volume":"65","author":"F F Zeng","year":"2015","journal-title":"Hypertension"},{"key":"ref23","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity\n                    relieved by dexamethasone","volume":"95","author":"D J Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes\n                    glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"R P Lifton","year":"1992","journal-title":"Nature"},{"key":"ref25","first-page":"3214","article-title":"Familial hyperaldosteronism type II: description of a large kindred and\n                    exclusion of the aldosterone synthase (CYP11B2) gene","volume":"83","author":"D J Torpy","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/jhh.2010.93","article-title":"Further study of chromosome 7p22 to identify the molecular basis of familial\n                    hyperaldosteronism type II","volume":"25","author":"K J Carss","year":"2011","journal-title":"J Hum Hypertens"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study\n                    (Primary Aldosteronism in Torino-GENetic forms)","volume":"58","author":"P Mulatero","year":"2011","journal-title":"Hypertension"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring\n                    nonglucocorticoid-remediable aldosteronism","volume":"93","author":"D S Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited\n                    mutations in the potassium channel KCNJ5","volume":"109","author":"U I Scholl","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing\n                    adenomas and primary aldosteronism","volume":"45","author":"U I Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes\n                    early-onset hypertension with primary aldosteronism","volume":"4","author":"U I Scholl","year":"2015","journal-title":"Elife"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.cmet.2013.10.005","volume":"18","author":"S Shibata","year":"2013","journal-title":"Cell Metab"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cmet.2013.10.010","article-title":"Angiotensin retains sodium by dephosphorylating mineralocorticoid receptors in\n                    renal intercalated cells","volume":"18","author":"J W Funder","year":"2013","journal-title":"Cell Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119249","article-title":"Angiotensin-independent Mechanism for Aldosterone Synthesis during Chronic\n                    Extracellular Fluid Volume Depletion","volume":"99","author":"S Okubo","year":"1997","journal-title":"J Clin Invest"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/HYPERTENSIONAHA.115.05873","volume":"66","author":"F Gioco","year":"2015","journal-title":"Hypertension"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: one node is\n                    the culprit?","volume":"99","author":"T Dekkers","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal\n                    glands","volume":"112","author":"K Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a\n                    preliminary study","volume":"99","author":"A H Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/jc.2011-2384","article-title":"18-hydroxycorticosterone, 18 hydroxy cortisol and 18-oxocortisol in the\n                    diagnosis of primary aldosteronism and its subtypes","volume":"97","author":"P Mulatero","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral\n                    adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"F Satoh","year":"2015","journal-title":"Hypertension"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF01476798","article-title":"Evidence for a subgroup of essential hypertensives with non-suppressible\n                    excretion of aldosterone during sodium loading","volume":"58","author":"A Helber","year":"1980","journal-title":"Klin Wochenschr"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2003-032149","article-title":"Distinguishing the antihypertensive and electrolyte effects of eplerenone","volume":"89","author":"D G Levy","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.109.136242","article-title":"Glucocorticoids activate cardiac mineralocorticoid receptors during experimental\n                    myocardial infarction","volume":"54","author":"A S Mihailidou","year":"2009","journal-title":"Hypertension"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/ndt\/gfs587","article-title":"Regression of left ventricular hypertrophy in patients with primary\n                    aldosteronism\/low-renin hypertension on low-dose spironolactone","volume":"28","author":"Y Ori","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1365-2362.2011.02531.x","article-title":"High prevalence of autonomous aldosterone secretion among patients with\n                    essential hypertension","volume":"41","author":"A Gouli","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary\n                    aldosteronism","volume":"45","author":"P Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0031-1301281","article-title":"Primary aldosteronism: are we missing the wood for the trees?","volume":"44","author":"J W Funder","year":"2012","journal-title":"Horm Metab Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: a clue to efficient\n                    treatment","volume":"22","author":"I K Eide","year":"2004","journal-title":"J Hypertens"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00424-014-1658-0","article-title":"Primary aldosteronism and salt","volume":"467","author":"J W Funder","year":"2015","journal-title":"Pflugers Arch"}],"container-title":["Hormone and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0035-1565182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T23:50:11Z","timestamp":1645573811000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0035-1565182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,20]]},"references-count":48,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2015,12,14]]},"published-print":{"date-parts":[[2015,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0035-1565182","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0018-5043","1439-4286"],"issn-type":[{"value":"0018-5043","type":"print"},{"value":"1439-4286","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,20]]}}}